Author:
Mayer Christine,Brucker Janina,Schuetz Florian,Domschke Christoph,Bechstein Sarah,Heil Jörg,Golatta Michael,Wallwiener Markus,Sohn Christof,Schneeweiss Andreas,Rom Joachim
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,General Medicine
Reference37 articles.
1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277–300. doi: 10.3322/caac.20073
2. Hennessy BT, Coleman RL, Markman M (2009) Ovarian cancer. Lancet 374(9698):1371–1382. doi: 10.1016/S0140-6736(09)61338-6
3. Bookman MA (2005) Standard treatment in advanced ovarian cancer in 2005: the state of the art. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc 15(Suppl 3):212–220. doi: 10.1111/j.1525-1438.2005.00444.x
4. du Bois A, Herrstedt J, Hardy-Bessard AC, Muller HH, Harter P, Kristensen G, Joly F, Huober J, Avall-Lundqvist E, Weber B, Kurzeder C, Jelic S, Pujade-Lauraine E, Burges A, Pfisterer J, Gropp M, Staehle A, Wimberger P, Jackisch C, Sehouli J (2010) Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer. J Clin Oncol Off J Am Soc Clin Oncol 28(27):4162–4169. doi: 10.1200/JCO.2009.27.4696
5. du Bois A LA, Meier W, AGO Ovarian Cancer Study Group (1999) Cisplatin/Paclitaxel vs Carboplatin/Paclitaxel in Ovarian Cancer: Update of an AGO Study Group Trial. ASCO Proceedings (18) Abstract 1374
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献